Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 15, 2021
Medpace Holdings, Inc. (Nasdaq: MEDP) will report its Q4 and fiscal 2020 financial results on February 15, 2021. A conference call will follow on February 16, 2021, at 9:00 a.m. ET, accessible via phone or webcast. Medpace, based in Cincinnati, offers Phase I-IV clinical development services to biotech and pharmaceutical industries, employing around 3,400 staff across 39 countries as of September 30, 2020. The company's focus includes oncology, cardiology, and more, aiming to accelerate the development of safe medical therapeutics.
- None.
- None.
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2020 financial results after the market close on Monday, February 15, 2021. The Company will host a conference call the following morning, Tuesday, February 16, 2021, at 9:00 a.m. ET to discuss these results.
To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 9646903.
To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.
A recording of the call will be available until Tuesday, February 23, 2021. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 9646903.
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 39 countries as of September 30, 2020.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005902/en/
FAQ
When will Medpace report its financial results?
What is the date and time of Medpace's conference call?
How can I participate in the Medpace conference call?
Where can I access the Medpace conference call webcast?
Is there a replay available for the Medpace conference call?
